Dr. Michael Grodin is professor of health law, bioethics and human rights at Boston University School of Public Health and a clinical medical ethicist for Boston Medical Center.

A May 16, 2013, piece from Stateline exploring the effects of Oklahoma’s law that states “patients who are disabled, elderly or terminally ill cannot be denied life-preserving treatments if they or their health proxies want it.”

A May 2013 Huffington Post and YouGov poll found that 50 percent of Americans think physician-assisted suicide should be legal, while 29 percent think it should be illegal.

Dr. Jerome Groopman is the Dina and Raphael Recanati Professor of Medicine at Harvard Medical School, Chief of Experimental Medicine at Beth Israel Deaconess Medical Center and one of the world’s leading researchers in cancer and AIDS. Contact Dr. Groopman through his website.

Courts in Montana will reconsider the state’s current lack of rulings on physician-assisted suicides, explains a Billings Gazette story published June 12, 2013. In 2009, the Supreme Court of Montana stated that nothing prevented physician-assisted suicides from being legal, but did not say clearly whether they are or not.

Sylvia A. Law is Elizabeth K. Dollard Professor of Law, Medicine and Psychiatry and co-director of the Arthur Garfield Hays Civil Liberties Program at New York University Law School.

Dr. Ezekiel J. Emanuel is the Diane Levy and Robert M. Levy University Professor in the department of medical ethics and health policy at the University of Pennsylvania.

The Society for Clinical Trials is a unique group of representatives from government, academia, industry, for-profit and non-profit sectors that share is a common desire to learn, while advancing the field of clinical research. Contact Elizabeth Franks.

Cancer Patients Alliance is a 501(c)(3) non-profit organization led by a Medical Director and a five-member scientific board of highly regarded specialists in oncology from around the world. Their mission is to promote awareness, increase education and further pancreatic cancer research.